Literature DB >> 19590195

Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility.

Kurt Pfannkuche1, Huamin Liang, Tobias Hannes, Jiaoya Xi, Azra Fatima, Filomain Nguemo, Matthias Matzkies, Marius Wernig, Rudolf Jaenisch, Frank Pillekamp, Marcel Halbach, Heribert Schunkert, Tomo Sarić, Juergen Hescheler, Michael Reppel.   

Abstract

AIMS: Induced pluripotent stem (iPS) cells have a developmental potential similar to that of blastocyst-derived embryonic stem (ES) cells and may serve as an autologous source of cells for tissue repair, in vitro disease modelling and toxicity assays. Here we aimed at generating iPS cell-derived cardiomyocytes (CMs) and comparing their molecular and functional characteristics with CMs derived from native murine ES cells. METHODS AND
RESULTS: Beating cardiomyocytes were generated using a mass culture system from murine N10 and O9 iPS cells as well as R1 and D3 ES cells. Transcripts of the mesoderm specification factor T-brachyury and non-atrial cardiac specific genes were expressed in differentiating iPS EBs. Using immunocytochemistry to determine the expression and intracellular organisation of cardiac specific structural proteins we demonstrate strong similarity between iPS-CMs and ES-CMs. In line with a previous study electrophysiological analyses showed that hormonal response to beta-adrenergic and muscarinic receptor stimulation was intact. Action potential (AP) recordings suggested that most iPS-CMs measured up to day 23 of differentiation are of ventricular-like type. Application of lidocaine, Cs+, SEA0400 and verapamil+ nifedipine to plated iPS-EBs during multi-electrode array (MEA) measurements of extracellular field potentials and intracellular sharp electrode recordings of APs revealed the presence of I(Na), I(f), I(NCX), and I(CaL), respectively, and suggested their involvement in cardiac pacemaking, with I(CaL) being of major importance. Furthermore, iPS-CMs developed and conferred force to avitalized ventricular tissue that was responsive to beta-adrenergic stimulation.
CONCLUSIONS: Our data demonstrate that the cardiogenic potential of iPS cells is comparable to that of ES cells and that iPS-CMs possess all fundamental functional elements of a typical cardiac cell, including spontaneous beating, hormonal regulation, cardiac ion channel expression and contractility. Therefore, iPS-CMs can be regarded as a potentially valuable source of cells for in vitro studies and cellular cardiomyoplasty. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590195     DOI: 10.1159/000227815

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  31 in total

Review 1.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 2.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 3.  Therapeutic opportunities: telomere maintenance in inducible pluripotent stem cells.

Authors:  Francoise A Gourronc; Aloysius J Klingelhutz
Journal:  Mutat Res       Date:  2011-05-13       Impact factor: 2.433

4.  Functional characterization and gene expression profiling of α-smooth muscle actin expressing cardiomyocytes derived from murine induced pluripotent stem cells.

Authors:  Shiva Prasad Potta; Xiaowu Sheng; John Antonydas Gaspar; Kesavan Meganathan; Smita Jagtap; Kurt Pfannkuche; Johannes Winkler; Jürgen Hescheler; Symeon Papadopoulos; Agapios Sachinidis
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 5.  Preclinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Bryon A Tompkins; Wayne Balkan; Johannes Winkler; Mariann Gyöngyösi; Georg Goliasch; Francisco Fernández-Avilés; Joshua M Hare
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

Review 6.  Functional cardiac tissue engineering.

Authors:  Brian Liau; Donghui Zhang; Nenad Bursac
Journal:  Regen Med       Date:  2012-03       Impact factor: 3.806

7.  Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.

Authors:  Hinh Ly
Journal:  World J Stem Cells       Date:  2011-10-26       Impact factor: 5.326

Review 8.  Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.

Authors:  Fikru B Bedada; Matthew Wheelwright; Joseph M Metzger
Journal:  Biochim Biophys Acta       Date:  2015-11-11

9.  Initial colony morphology-based selection for iPS cells derived from adult fibroblasts is substantially improved by temporary UTF1-based selection.

Authors:  Kurt Pfannkuche; Azra Fatima; Manoj K Gupta; Rebecca Dieterich; Jürgen Hescheler
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

10.  Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar.

Authors:  Manoj K Gupta; Damir J Illich; Andrea Gaarz; Matthias Matzkies; Filomain Nguemo; Kurt Pfannkuche; Huamin Liang; Sabine Classen; Michael Reppel; Joachim L Schultze; Jürgen Hescheler; Tomo Sarić
Journal:  BMC Dev Biol       Date:  2010-09-15       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.